These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 11437468)

  • 1. The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration.
    Bauss F; Lang K; Dony C; Kling L
    Growth Horm IGF Res; 2001 Feb; 11(1):1-9. PubMed ID: 11437468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of recombinant human insulin-like growth factor (rhIGF)-1 and rhIGF-1/IGF binding protein-3 administration on rat osteopenia induced by ovariectomy with concomitant bilateral sciatic neurectomy.
    Narusawa K; Nakamura T; Suzuki K; Matsuoka Y; Lee LJ; Tanaka H; Seino Y
    J Bone Miner Res; 1995 Dec; 10(12):1853-64. PubMed ID: 8619365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
    Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
    J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit of systemically administered rhIGF-I and rhIGF-I/IGFBP-3 on cancellous bone in ovariectomized rats.
    Bagi CM; Brommage R; Deleon L; Adams S; Rosen D; Sommer A
    J Bone Miner Res; 1994 Aug; 9(8):1301-12. PubMed ID: 7526611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic administration of rhIGF-I or rhIGF-I/IGFBP-3 increases cortical bone and lean body mass in ovariectomized rats.
    Bagi CM; DeLeon E; Brommage R; Adams S; Rosen D; Sommer A
    Bone; 1995 Apr; 16(4 Suppl):263S-269S. PubMed ID: 7542899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats.
    Dunstan CR; Boyce R; Boyce BF; Garrett IR; Izbicka E; Burgess WH; Mundy GR
    J Bone Miner Res; 1999 Jun; 14(6):953-9. PubMed ID: 10352104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary protein restriction lowers plasma insulin-like growth factor I (IGF-I), impairs cortical bone formation, and induces osteoblastic resistance to IGF-I in adult female rats.
    Bourrin S; Ammann P; Bonjour JP; Rizzoli R
    Endocrinology; 2000 Sep; 141(9):3149-55. PubMed ID: 10965885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic alcohol consumption during male rat adolescence impairs skeletal development through effects on osteoblast gene expression, bone mineral density, and bone strength.
    Wezeman FH; Emanuele MA; Emanuele NV; Moskal SF; Woods M; Suri M; Steiner J; LaPaglia N
    Alcohol Clin Exp Res; 1999 Sep; 23(9):1534-42. PubMed ID: 10512321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoblast-specific expression of insulin-like growth factor-1 in bone of transgenic mice induces insulin-like growth factor binding protein-5.
    Rutter MM; Markoff E; Clayton L; Akeno N; Zhao G; Clemens TL; Chernausek SD
    Bone; 2005 Feb; 36(2):224-31. PubMed ID: 15780948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats.
    Ammann P; Shen V; Robin B; Mauras Y; Bonjour JP; Rizzoli R
    J Bone Miner Res; 2004 Dec; 19(12):2012-20. PubMed ID: 15537445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local anabolic effects of growth hormone on intact bone and healing fractures in rats.
    Andreassen TT; Oxlund H
    Calcif Tissue Int; 2003 Sep; 73(3):258-64. PubMed ID: 14667139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of ovariectomized rats with the complex of rhIGF-I/IGFBP-3 increases cortical and cancellous bone mass and improves structure in the femoral neck.
    Bagi CM; DeLeon E; Brommage R; Rosen D; Sommer A
    Calcif Tissue Int; 1995 Jul; 57(1):40-6. PubMed ID: 7545533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of insulin-like growth factor binding protein-2 as a biochemical surrogate marker for the in vivo effects of recombinant human insulin-like growth factor-1 in mice.
    Bhat RV; Engber TM; Zhu Y; Miller MS; Contreras PC
    J Pharmacol Exp Ther; 1997 Apr; 281(1):522-30. PubMed ID: 9103540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with growth hormone and IGF-I in growing rats increases bone mineral content but not bone mineral density.
    Rosen HN; Chen V; Cittadini A; Greenspan SL; Douglas PS; Moses AC; Beamer WG
    J Bone Miner Res; 1995 Sep; 10(9):1352-8. PubMed ID: 7502707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone (1-34) increased total body bone mass in aged female rats.
    Simmons HA; Pirie CM; Thompson DD; Ke HZ
    J Pharmacol Exp Ther; 1998 Jul; 286(1):341-4. PubMed ID: 9655878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of growth hormone on bone: bone mineral density, trabecular bone volume, and alkaline phosphatase improve or are restored in the dwarf rat treated with growth hormone.
    Wright NM; Renault J; Hollis B; Bell NH; Key LL
    J Bone Miner Res; 1995 Jan; 10(1):127-31. PubMed ID: 7747619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats.
    Bonnet N; Benhamou CL; Brunet-Imbault B; Arlettaz A; Horcajada MN; Richard O; Vico L; Collomp K; Courteix D
    Bone; 2005 Nov; 37(5):622-33. PubMed ID: 16157516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental changes in pharmacokinetics of recombinant human insulin-like growth factor-I in rats.
    Higaki K; Matsumoto Y; Fujimoto R; Kurosaki Y; Kimura T
    Res Commun Mol Pathol Pharmacol; 1997 Aug; 97(2):115-24. PubMed ID: 9344224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graded doses of recombinant interleukin-1beta induce generalized osteopenia in rats without altering skeletal growth and joint integrity.
    del Pozo E; Popp AW; MacKenzie A; Perrelet R; Lamberts SW; Lippuner K
    Horm Res; 2005; 64(2):88-95. PubMed ID: 16155378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.